|Chemical and physical data|
|Molar mass||501.427 g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Ibipinabant (SLV319, BMS-646,256) is a drug used in scientific research which acts as a potent and highly selective CB1 antagonist. It has potent anorectic effects in animals, and was researched for the treatment of obesity, although CB1 antagonists as a class have now fallen out of favour as potential anorectics following the problems seen with rimonabant, and so ibipinabant is now only used for laboratory research, especially structure-activity relationship studies into novel CB1 antagonists.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|